The controlled release of two drugs, i.e. the sodium salt of diclofenac and propranolol was studied, by using low molecular weight D,L Poly(lactic acid) as a matrix. Tabletsof the above polymer containing those drugswere immersed into bufferswith variouspH valuesand delivery was recorded as a function of time, via UV-spectroscopy. The results showed that the polymer is appropriate for such biomedical applications, as generally, it ensures complete drug delivery within 45–60 days, which is acceptable for most cases. On the other hand, the release rate depends on many parameters including the interactionsamong drug, matrix and the surrounding liquid, which adds complexity to the process and requires careful investigation for proper design of a controlled release system.
1. Wada, R., Hyon, S.H. and Ikada, Y. (1990). Lactic acid oligomer micro-spheres containing hydrophilic drugs. J. Pharm. Sci., 79: 919–924.
2.
2. Avgoustakis, K. and Nixon, J.R. (1991). Biodegradable controlled release tablets, 1: Preparative variables affecting the properties of poly(lactideco-glycolide). Intern. J. Pharm., 70: 77–85.
3.
3. Andreopoulos, A.G. and Plytaria, M. (1998). Release of drugs from polymeric hydrogels. J. Biomater. Appl., 12: 291–299.
4.
4. Nitsche, M.J. and Banakar, U.V. (1994). Implantable drug delivery. J. Biomater. Appl., 8: 247–284.
5.
5. Andreopoulos, A.G. and Tarantili, P.A. (2001). Xanthan gum as a carrier for controlled release of drugs. J. Biomater. Appl., 16: 34–46.
6.
6. Shih, C., Higuchi, T. and Himmelstein, K.J. (1984). Drug delivery from catalyzed erodible polymeric matrices of poly(ortho esters). Biomaterials, 5: 237–240.
7.
7. Lee, P.I. (1983). Dimensional changes during release from glassy hydrogel matrix. Polym. Commun., 24: 45–47.
8.
8. Ali, A.M., Doherty, P.J. and Williams, D.F. (1993). Mechanism of polymer degradation in implantable devices: 2. Poly(D, L Lactic acid). J. Biomed. Mater. Res., 27: 1409–1418.
9.
9. Giamarellou, E. (1991). New Quinolones, in Infections and Antimicrobial Chemotherapy. In: Sfikakis, P. and Giamarellou, E. (eds.), Vol. 15. Athens: Medical Press Litsas pp. 199–228.
10.
10. Andreopoulos, A.G., Hatzi, E.C. and Doxastakis, M. (1999). Synthesis and Propertiesof Poly(lactic acid). J. Mater. Sci., Mater. in Med., 10: 29–33.
11.
11. Zwiers, R.J.M., Gogolewski, S. and Pennings, A.J. (1983). General Crystallization behaviour of Poly(L-lactic acid) PLLA: 2. Eutectic Crystallization of PLLA. Polymer, 24: 167–174.
12.
12. Greco, P. and Martuscelli, E. (1989). Crystallization and thermal behaviour of Poly(D(-)-3-hydroxybutyrate) based blends. Polymer, 30: 1475–1483.
13.
13. Coffin, M.D. and McGinity, J.W. (1992). Biodegradable pseudolatexes: the chemical stability of poly(D, L lactide) and poly("-caprolactone) nanoparticles in aqueousmedia. Pharmaceutical Research, 9: 200–205.
14.
14. Eling, B., Gogolewski, S. and Pennings, A.J. (1982). Biodegradable materials of Poly(L-lactic acid): 1. Melt-spun and solution-spun fibres. Polymer, 23: 1587–1593.
15.
15. Gangadharam, P., Ashtekar, D., Faphi, D. and Wise, D. (1991). Sustained release of isoniazid in vivo from a single implant of a biodegradable polymer. Tubercle, 72: 115–122.
16.
16. Andreopoulos, A.G. (1995). Controlled release of Newer Quinolone from biodegradable systems based on Poly(lactic acid). J. Biomater. Appl., 10: 163–168.
17.
17. Wise, McCormick, G., Willet, L., Anderson, J. and Howes (1978). Sustained release of sulphadiazine. J. Pharm. Pharmac., 30: 686–689.
18.
18. Ammoury, H., Fessi, J., Devissaquet, M., Dubrasqet, S. and Benita (1991). Jejunal absorption, pharmacological activity and pharmacokinetic evaluation of indomathacin-loaded Poly(D, L-lactide) and Poly(isobutyl-cyano-acrylate) nanocapsules in rats. Pharm. Res., 8: 101–105.
19.
19. Ichihara, K.Sakamoto, K., Mori, M. and Akadi (1989). Transcatheter arterial chemoembolization therapy for hepatocellular carnicoma using poly(lactic acid) microspheres containing aclarubicin hydrochloride. Cancer Research, 49: 4357–4362.
20.
20. Ike, Y., Shimizu, Y., Ikada, S., Watanabe, T., Natsume, R., Wada, S.H., Hyon, S. and Hitomi (1991). Biodegradation and antitumor effect of adriamycin-containing Poly(L-lactic acid). Biomaterials, 12: 757–762.
21.
21. Bottenberg, C., DeMuynck, S., Bouckaert, D., Coomans, D., Slop, J.P. and Remon (1991). Development and testing of bioadhesive fluoride containing slow release tablets for oral use. Part 1: In vivo and in vitro bioadhesion. Proceed. Intern. Control. Res. Biaoct. Mater., 18: 631–632.
22.
22. Andreopoulos, A.G. (1994). Plasticization of biodegradable polymers for use in controlled release. Clinical Materials, 15: 89–92.
23.
23. Andreopoulos, A.G., Korakis, T., Dounis, E., Kanellakopoulou, K., Anastasiadis, A. and Tzivelekis, P. (1996). In vitro release of new quinolones from biodegradable systems. A comparative study. J. Biomater. Appl., 10: 338–347.
24.
24. Ajioka, M., Suizu, H., Higuchi C. and Kashima, T. (1998). Aliphatic polyesters and their copolymers synthesized through direct condensation polymerization. Polym. Degrad. and Stab., 59: 137–143.
25.
25. Gohem, M.C., Patel, M.M., Kaul, J.S., Patel, R.B., Patel, S.R. and Jani, T.R. (1996). An investigation of the synthesis of poly(D, L-lactic acid) and preparation of microspheres containing indomethacin. Drug Develop. and Industr. Pharm., 22: 637–643.
26.
26. Proikakis, C.S, Tarantili, P.A. and Andreopoulos, A.G.Synthesis and characterization of low molecular weight polylactic acid. Accepted for publication in J. Elastomers and Plastics.
27.
27. Aso Y., Yoshioka, S., Li Wan Po, A. and Terao, T. (1994). Effect of temperature on mechanisms of drug release and matrix degradation of poly(D, L Lactide) microspheres. J. Control. Release, 31: 33–39.
